Indoco Remedies Ltd (BOM:532612)
₹ 376.45 8.55 (2.32%) Market Cap: 34.69 Bil Enterprise Value: 41.15 Bil PE Ratio: 44.57 PB Ratio: 3.06 GF Score: 79/100

Q3 2021 Indoco Remedies Ltd Earnings Call Transcript

Feb 09, 2021 / 09:00AM GMT
Release Date Price: ₹314.55 (-0.52%)
Operator

Ladies and gentlemen, good day, and welcome to the Q3 FY '21 Earnings Conference Call of Indoco Remedies Limited, hosted by Nirmal Bang Institutional Equities. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Vishal Manchanda from Nirmal Bang Institutional Equities. Thank you, and over to you.

Vishal Manchanda
Nirmal Bang Securities Pvt. Ltd., Research Division - Research Analyst

Thank you, Rituja. Hi, good afternoon, everyone, and welcome to the Q3 FY '21 Earnings Call of Indoco Remedies Limited. We thank the Indoco management for giving us an opportunity to host the call. Today, we have with us the senior management of the company represented by Mr. Aditi Panandikar, Managing Director; Mr. Sundeep Bambolkar, Joint Managing Director; Mr. Mandar Borkar, Chief Financial Officer; and Mr. Vilas Nagare, President, Corporate Affairs and M&A. Over to you, sir.

Sundeep V. Bambolkar
Indoco Remedies Limited - Joint MD & Executive Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot